Detalles de la búsqueda
1.
Everolimus-facilitated calcineurin inhibitor reduction in Asian de novo kidney transplant recipients: 2-year results from the subgroup analysis of the TRANSFORM study.
Clin Transplant
; 35(10): e14415, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34216395
2.
Wound healing adverse events in kidney transplant recipients receiving everolimus with reduced calcineurin inhibitor exposure or current standard-of-care: insights from the 24-month TRANSFORM study.
Expert Opin Drug Saf
; 19(10): 1339-1348, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32633157
3.
Safety of Everolimus With Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplants: An Analysis From the Randomized TRANSFORM Study.
Transplantation
; 103(9): 1953-1963, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30801548
Resultados
1 -
3
de 3
1
Próxima >
>>